ABBV vs BAX
By Alex · Tickerpine
AbbVie Inc. vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | BAX |
|---|---|---|
| Price | $253.35 | $22.04 |
| Market cap | $447.62B | $11.38B |
| P/E ratio | 123.6 | — |
| ROE | — | -15.01% |
| Profit margin | 5.79% | -9.70% |
| Revenue growth | 12.40% | 2.90% |
| Dividend yield | 2.73% | 0.91% |
| Beta | 0.31 | 0.64 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs BAX in plain English
- ABBV is the bigger company — about 39.3× the market cap of BAX.
- ABBV is growing revenue faster (12% vs 3%).
- ABBV has the higher dividend yield (2.73% vs 0.91%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.